Communication challenges with aphasia can exacerbate caregiving stress
Dr. Roberts and her colleague Dr. Emily Rogalski at the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease at Northwestern University in Chicago, Illinois recently completed enrollment for the Communication Bridge-2 study, the largest randomized control trial of speech-language therapy for persons with primary progressive aphasia. Delivered through telehealth, the Communication Bridge-2 study enrolled participants from four countries including Canada, New Zealand, the United Kingdom, and the United States. Results of the trial are expected to be published in 2023.
